CA2855923A1 - Process for the preparation of febuxostat polymorphs - Google Patents

Process for the preparation of febuxostat polymorphs Download PDF

Info

Publication number
CA2855923A1
CA2855923A1 CA2855923A CA2855923A CA2855923A1 CA 2855923 A1 CA2855923 A1 CA 2855923A1 CA 2855923 A CA2855923 A CA 2855923A CA 2855923 A CA2855923 A CA 2855923A CA 2855923 A1 CA2855923 A1 CA 2855923A1
Authority
CA
Canada
Prior art keywords
febuxostat
solvent
process according
crystalline form
ester
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA2855923A
Other languages
English (en)
French (fr)
Inventor
Ramakoteswara Rao Jetti
Balakrishna Reddy Bhogala
Satish Beeravelli
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mylan Laboratories Ltd
Original Assignee
Mylan Laboratories Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mylan Laboratories Ltd filed Critical Mylan Laboratories Ltd
Publication of CA2855923A1 publication Critical patent/CA2855923A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/56—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
    • B65B—MACHINES, APPARATUS OR DEVICES FOR, OR METHODS OF, PACKAGING ARTICLES OR MATERIALS; UNPACKING
    • B65B31/00—Packaging articles or materials under special atmospheric or gaseous conditions; Adding propellants to aerosol containers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Dispersion Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Mechanical Engineering (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
CA2855923A 2011-11-15 2012-11-14 Process for the preparation of febuxostat polymorphs Abandoned CA2855923A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IN3909/CHE/2011 2011-11-15
IN3909CH2011 2011-11-15
PCT/IN2012/000748 WO2013076738A2 (en) 2011-11-15 2012-11-14 Process for the preparation of febuxostat polymorphs

Publications (1)

Publication Number Publication Date
CA2855923A1 true CA2855923A1 (en) 2013-05-30

Family

ID=47710247

Family Applications (1)

Application Number Title Priority Date Filing Date
CA2855923A Abandoned CA2855923A1 (en) 2011-11-15 2012-11-14 Process for the preparation of febuxostat polymorphs

Country Status (7)

Country Link
US (1) US20140283486A1 (https=)
EP (1) EP2780335B1 (https=)
JP (1) JP2014533297A (https=)
CN (1) CN104114545B (https=)
AU (1) AU2012342011A1 (https=)
CA (1) CA2855923A1 (https=)
WO (1) WO2013076738A2 (https=)

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2092580T3 (es) * 1990-11-30 1996-12-01 Teijin Ltd Derivado de 2-ariltiazol y composicion farmaceutica que contiene el mismo.
CA2566652C (en) 1998-06-19 2008-10-21 Teijin Limited Polymorphic modifications of 2-(3-cyano-4-isobutyloxyphenyl)-4-methyl-5-thiazole-carboxylic acid and processes for the preparation thereof
CN101139325B (zh) * 2006-09-07 2010-05-12 上海医药工业研究院 2-(3-氰基-4-异丁氧基苯基)-4-甲基-5-噻唑甲酸晶型及其制备方法
CN100546985C (zh) * 2007-06-29 2009-10-07 上海华拓医药科技发展股份有限公司 非布他特微晶及其组合物
CN101412700B (zh) * 2007-10-19 2011-06-08 上海医药工业研究院 非布司他的晶型及其制备方法
CN101386605B (zh) * 2008-10-23 2010-09-08 中国科学院上海药物研究所 非布司他新型晶体及其制备方法
CN101759656B (zh) * 2008-12-12 2013-04-03 重庆医药工业研究院有限责任公司 非布司他新晶型及其制备方法
CN101768150B (zh) * 2009-01-05 2014-08-06 常州市第四制药厂有限公司 2-[3-氰基-4-异丁氧基苯基]-4-甲基噻唑-5-甲酸晶型及其制备方法
CN101857578A (zh) * 2009-04-08 2010-10-13 北京海步国际医药科技发展有限公司 非布司他新晶型及制备方法
ES2395381T3 (es) 2009-06-10 2013-02-12 Teva Pharmaceutical Industries Ltd. Formas cristalinas de Febuxostat
CN101817801A (zh) * 2009-08-12 2010-09-01 北京红惠新医药科技有限公司 2-(3-氰基-4-异丁氧基苯基)-4-甲基-5-噻唑甲酸新晶型k及其他晶型的制备方法
CN101671315B (zh) * 2009-08-19 2011-06-22 何广卫 非布索坦的新晶型及其制备方法
WO2011080651A2 (en) 2009-12-31 2011-07-07 Ranbaxy Laboratories Limited Polymorphic forms of febuxostat
EP2536699A2 (en) * 2010-02-19 2012-12-26 Cadila Healthcare Limited Substantially pure salts of febuxostat and processes for preparation thereof
AU2011222462A1 (en) * 2010-03-04 2012-09-27 Ranbaxy Laboratories Limited Polymorph of 2-[3-cyano-4-(2-methylpropoxy)phenyl]-4-methylthiazole-5-carboxylic acid
EP2563768A4 (en) * 2010-04-29 2013-07-31 Reddys Lab Ltd Dr MANUFACTURE OF FEBUXOSTAT
TW201217347A (en) * 2010-07-13 2012-05-01 Interquim Sa Process for preparing the crystalline form a of febuxostat
AR081267A1 (es) * 2010-07-13 2012-07-18 Interquim Sa Procedimiento de obtencion de la forma cristalina a del febuxostat
AU2012241378A1 (en) * 2011-04-15 2013-10-31 Sun Pharmaceutical Industries Limited Febuxostat solid dispersion

Also Published As

Publication number Publication date
NZ625043A (en) 2016-06-24
CN104114545B (zh) 2018-06-01
US20140283486A1 (en) 2014-09-25
WO2013076738A3 (en) 2013-10-10
CN104114545A (zh) 2014-10-22
JP2014533297A (ja) 2014-12-11
EP2780335B1 (en) 2019-04-10
WO2013076738A2 (en) 2013-05-30
EP2780335A2 (en) 2014-09-24
AU2012342011A1 (en) 2014-06-05

Similar Documents

Publication Publication Date Title
AU2015260762B2 (en) N-[5-(aminosulfonyl)-4-methyl-1,3-thiazol-2-yl]-n-methyl-2-[4-(2-pyridinyl)phenyl]acetamide mesylate monohydrate
CA2795157C (en) Raltegravir salts and crystalline forms thereof
CN103649047B (zh) 用于制备前列腺素酰胺的方法
EP1966186A1 (en) Process for the preparation of imatinib
EP1592668A1 (en) Crystalline forms of pitavastatin calcium
WO2014020555A2 (en) An improved process for the preparation of dabigatran etexilate mesylate
WO2008019057A2 (en) Polymorphs of solifenacin intermediate
CA2855923A1 (en) Process for the preparation of febuxostat polymorphs
AU776696B2 (en) Process for preparing (1R,2S,4R) -(-)-2-((2'- (n,n-dimethylamino) -ethoxy)) -2-(phenyl) -1,7,7-tri- (methyl) -bicyclo (2.2.1) heptane and pharmaceutically acceptable acid addition salts thereof
CA2061538A1 (en) 2-substituted quinolines, processes for their preparation and their use in medicaments
EP2231613B1 (en) Montelukast benzhydryl piperazine salts and process for preparation thereof
JP2019023224A (ja) ２−アミノ−１，３−プロパンジオール化合物およびその塩の製造のための方法
JP2020503257A (ja) アモルファスサクビトリルバルサルタン三ナトリウムおよびその調製のためのプロセス
WO2018047131A1 (en) Amorphous eluxadoline
EP2718272A2 (en) Process for febuxostat
JP2007112800A (ja) アンジオテンシンｉｉ拮抗化合物の製造方法
NZ625043B2 (en) Process for the preparation of febuxostat polymorphs
CN103275021B (zh) N-二氯乙酰基-6,7-二氯-1,2,3,4-四氢喹喔啉及其制备方法
WO2017208251A1 (en) A new stable polymorph of brexpiprazole and process for preparation thereof
JPWO2023058645A5 (https=)
WO2017081014A1 (en) Process for the preparation of eltrombopag olamine
WO2006001026A1 (en) Irbesartan polymorphs
WO2007054970A2 (en) Novel polymorphic forms of (s)-(-)-2-amino-6-(n- propylamino) 4,5,6,7- tetrahydrobenzothiazole
WO2010118757A1 (en) Improved process for the preparation of fluvastatin and salts thereof
HUP0600347A2 (en) Process for the preparation of {2-[4-(1,2-benzisothiazol-3-yl)-1-piperazinyl]ethyl}-6-chloro-1,3-dihydro-2h-indol-2-one (ziprasidon) and the intermediate

Legal Events

Date Code Title Description
EEER Examination request

Effective date: 20151030

FZDE Discontinued

Effective date: 20180614